首页 | 本学科首页   官方微博 | 高级检索  
     

头孢氨苄胃漂浮缓释片的制备与质量评价
引用本文:祁静波,王敏,谢鹏,李秋艳. 头孢氨苄胃漂浮缓释片的制备与质量评价[J]. 西北药学杂志, 2020, 0(1): 95-99
作者姓名:祁静波  王敏  谢鹏  李秋艳
作者单位:1.唐山市协和医院药剂科;2.唐山职业技术学院
摘    要:目的制备头孢氨苄胃漂浮缓释片,并考察其漂浮延迟时间及体外药物释放度。方法采用粉末直接压片工艺制备头孢氨苄胃漂浮缓释片,采用单因素实验方法筛选得到影响头孢氨苄胃漂浮缓释片体外漂浮延迟时间、漂浮时间和释放度的关键性辅料用量范围,最终以羟丙甲纤维素(HPMC K15M)用量、碳酸氢钠用量以及压片主压力作为考察因素,以头孢氨苄胃漂浮缓释片的漂浮延迟时间和1,4和8 h时间点的药物释放度作为评价指标,通过Box-Behnken实验设计优化得到头孢氨苄胃漂浮缓释片处方设计空间,并在设计空间任取一点连续制备3批头孢氨苄胃漂浮缓释片,评价其漂浮延迟时间及体外释放度。结果优化得到头孢氨苄胃漂浮缓释片的处方设计空间,每片HPMC K15M用量为260 mg,碳酸氢钠用量为60 mg,压片主压力为8 kN,制备的头孢氨苄胃漂浮缓释片漂浮延迟时间仅为12.1±0.5 min,在12 h内药物释放平缓,无药物突释。结论通过Box-Behnken实验设计优化得到的头孢氨苄胃漂浮缓释片处方,漂浮延迟时间较短,12 h维持漂浮状态,药物释放平稳。

关 键 词:头孢氨苄  胃漂浮缓释片  Box-Behnken实验设计  漂浮延迟时间  体外释放度

Preparation and quality evaluation of Cephalexin Gastric Floating Sustained-Release Tablets
QI Jingbo,WANG Min,XIE Peng,LI Qiuyan. Preparation and quality evaluation of Cephalexin Gastric Floating Sustained-Release Tablets[J]. Northwest Pharmaceutical Journal, 2020, 0(1): 95-99
Authors:QI Jingbo  WANG Min  XIE Peng  LI Qiuyan
Affiliation:(Department of Pharmacy,Tangshan Union Hospital,Tangshan 063000,China;Tangshan Vocation&Technical College,Tangshan 063000,China)
Abstract:Objective To prepare Cephalexin Gastric Floating Sustained-Release Tablets and investigate their floating delay time and drug release in vitro.Methods Cephalexin Gastric Floating Sustained-Release Tablets were prepared by direct compression method.The single-factor experiment method was used to screen the key adjuvant dosage range affecting the floating delay time,floating time and drug release of Cephalexin Gastric Floating Sustained-Release Tablets.Finally,the amount of HPMC K15M,the amount of sodium bicarbonate and the main pressure were taken as the investigation factors,and the floating delay time and at the time points drug dissolution of 1,4 and 8 h were used as the evaluation index.The formulation design space of Cephalexin Gastric Floating Sustained-Release Tablets was optimized by Box-Behnken experiment design,and 3 consecutive batches of Cephalexin Gastric Floating Sustained-Release Tablets were taken in the design space to evaluate the floating delay time and drug release in vitro.Results The formulation design space of Cephalexin Gastric Floating Sustained-Release Tablets was optimized by experiment design.The amount of HPMC K15M was 260 mg per tablet,the amount of sodium bicarbonate was 60 mg per tablet,and the main pressure was 8 kN.The prepared Cephalexin Gastric Floating Sustained-Release Tablets had a floating delay time of only 12.1±0.5 min,and the drug was gently released within 12 h.Conclusion In this study,the preparation of Cephalexin Gastric Floating Sustained-Release Tablets was optimized by Box-Behnken experiment design.The floating delay time was short,the floating state was maintained for 12 h,and the drug release was stable.It is expected to further carry out in vivo pharmacokinetic studies.
Keywords:cephalexin  gastric floating sustained-release tablets  Box-Behnken experiment design  floating delay time  in vitro drug release
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号